Aclaris Therapeutics
Walter Smith currently serves as a scientific and business development consultant. He was previously Aclaris’ Senior Vice President, Research and Development and has more than 40 years of pharmaceutical experience.
Prior to joining Aclaris, Walter was CEO of Confluence Life Sciences, Inc., and Vice President and Global Head of Pfizer’s Inflammation/Immunology research therapeutic area. In his various management roles, he led licensing and portfolio management teams along with line organizations that have delivered several new chemical entities to market. Walter is a board member of the Arthritis Foundation and serves as a member of its Medical and Scientific Advisory Committee.
Walter received his Bachelor of Science in bacteriology and a Master of Science in Immunology from the University of Wisconsin-Madison.
This person is not in any teams
This person is not in any offices
Aclaris Therapeutics
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options.